Jenny is leads the Synthetic Biology platform where she oversees research activities including a Department of Energy grant on genome engineering tools, Validation Projects for translational research, and Platform Projects for early-stage research. In this role, she also manages 50-60 staff, postdoctoral fellows, and students with Core Faculty member George Church. In addition, she leads a Validation Project that develops new models to find better treatment options for bipolar disorder. This project also uses human cerebral organoids as a model for bipolar and other neurological disorders and neurodegeneration. Utilizing her interdisciplinary background, she frequently collaborates with and advises multiple Wyss teams on projects relating to diagnostics and high throughput sequencing and assay design using her skills in advanced microscopy and optics. Jenny has a PhD degree in chemistry from Tufts University (advised by David Walt), postdoctoral training in immunology at Massachusetts General Hospital, Harvard Medical School. She was previously faculty at MGH. She is also currently Lecturer in the Department of Genetics at Harvard Medical School.
Jenny Tam, Ph.D.
Director, Synthetic Biology